|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for credit losses | |||||
| Loss on sale of investments | |||||
| Net amortization of investment securities and assets | |||||
| Net amortization on borrowings | |||||
| Stock-based compensation expense | |||||
| Gain on sale of premises and equipment, net of impairment | |||||
| Gain on sale of closed branches | |||||
| Closed Branches | |||||
| Equipment Finance Business | |||||
| Gain on sale of foreclosed assets and other real estate owned | |||||
| Gain on sale of mortgage loans held for sale | |||||
| Gain on sale of branches | |||||
| (Gain) loss on sale of loans | |||||
| Loss on early extinguishment of debt | |||||
| Deferred income taxes | |||||
| Income from bank owned life insurance | |||||
| Originations of mortgage loans held for sale | |||||
| Proceeds from sale of mortgage loans held for sale | |||||
| Changes in assets and liabilities: | |||||
| Interest receivable | |||||
| Assets held in trading accounts | |||||
| Other assets | |||||
| Accrued interest and other liabilities | |||||
| Income taxes payable | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Net change in loans | |||||
| Proceeds from sale of loans | |||||
| Proceeds from sale of closed branches | |||||
| Decrease in due from banks - time | |||||
| Purchases of premises and equipment, net | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from sale of foreclosed assets and other real estate owned | |||||
| Proceeds from sale of available-for-sale securities | |||||
| Proceeds from maturities of available-for-sale securities | |||||
| Purchases of available-for-sale securities | |||||
| Proceeds from maturities of held-to-maturity securities | |||||
| Purchases of held-to-maturity securities | |||||
| Proceeds from bank owned life insurance death benefits | |||||
| Purchases of bank owned life insurance | |||||
| Surrender of bank owned life insurance | |||||
| Cash received in business combinations, net | |||||
| Disposition of assets and liabilities held for sale | |||||
| Sale of equipment finance business | |||||
| Net cash provided by (used in) investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Net change in deposits | |||||
| Proceeds from issuance of other borrowed funds | |||||
| Proceeds from issuance of subordinated notes | |||||
| Repayments of other borrowed funds | |||||
| Repayments of subordinated debentures | |||||
| Dividends paid on preferred stock | |||||
| Dividends paid on common stock | |||||
| Net change in other borrowed funds | |||||
| Net change in federal funds purchased and securities sold under agreements to repurchase | |||||
| Issuance of common stock | |||||
| Net shares cancelled under stock compensation plans | |||||
| Shares issued under employee stock purchase plan | |||||
| Repurchase of common stock | |||||
| Retirement of preferred stock | |||||
| Net cash used in financing activities | |||||
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS, END OF YEAR | |||||
Loading...